Advanced Dry AMD With Geographic Atrophy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Dry AMD With Geographic Atrophy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06557460

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

This is a Phase IIb randomized, clinical trial designed to assess the safety and efficacy of unilateral implantation of the CPCB-RPE1 implant in subjects with g…

United States24 participantsStarted 2025-08-01

Treatment: Surgical implantation of the CPCB-RPE1 implant

All recent trials (11 shown)

Active — Not RecruitingPhase 1/2

NCT02286089

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-derived retinal pigment epithelial (RPE) cel…

United States, Israel24 participantsStarted 2015-04-01

Treatment: OpRegen

CompletedPhase 1

NCT03144999

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over age 60. AMD is classified as wet and dry. Wet AMD constitutes 10…

United States17 participantsStarted 2017-03-29

Treatment: AAVCAGsCD59

Advanced Dry AMD With Geographic Atrophy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

All recent trials (11 shown)

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

All recent trials (11 shown)

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced D…

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geograph…

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Mac…

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Deg…

Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epitheli…